BEAT HeartBeam Inc
3,635
$2.07
$0.04
(1.90%)
| Watchers | 3,635 |
| 52-Wk Low | $1.06 |
| 52-Wk High | $3.74 |
| Market Cap | $54.5M |
| Volume | 17,338.00 |
| 52-Wk High | $3.74 |
| 52-Wk Low | $1.06 |
HeartBeam AIMIGo Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards ProgramBusiness Wire • 6 days ago
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, today announced that HeartBeam AIMIGo has been selected...
Share to Feed
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has reported its financial and operational results for...
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, will hold a conference call on Thursday May 9, 2024 at...
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, today announced new data demonstrating that applying the...
Related Stocks: NAS:BEAT...
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has reported its financial and operational results for...
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, announced today that it has enrolled the first patients...
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, announced today that it has received two new patents on...